President and Chief Executive Officer · NextCure, Inc. (NXTC)

Michael Richman

A named executive officer of NextCure in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$941,692

Salary $609,258Stock awards $0

FY2024: $1,510,939

1st of 3 named executive officers at NextCure by FY2025 total.

3 named officers on file for NextCure, FY2025

Michael Richman’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • NXTC’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how NextCure’s whole pay program stands against its peers

  • NextCure’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NXTC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 24, 2026 (DEF 14A).

Free

Get Michael Richman’s full pay file as a PDF — free

More than this page: up to 10 years of Michael’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Michael Richman compensation by year

NextCure Summary Compensation Table · all 2 fiscal years held
In US dollars, as NextCure reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$591,483$609,258
Bonus$0$0
Stock awards$0$0
Option awards$658,240$189,170
Non-equity incentive$240,500$122,000
Pension and deferred compensation$0$0
All other$20,716$21,264
Total$1,510,939$941,692

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: NextCure, Inc. DEF 14A filed April 24, 2026, accession 0001104659-26-048591, and prior-year filings. Open the filing on EDGAR.

How this page was built: the NextCure, Inc. filed document, accession 0001104659-26-048591. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.

$1.5M
$942K
FY24
FY25
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option455—$66.84
Option7,510—$18.60
Option13,259—$14.64
Option25,458—$9.66

Per the Outstanding Equity Awards at Fiscal Year-End table in NextCure, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

NextCure’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Michael Richman · this pagePresident and Chief Executive Officer$941,692
Udayan GuhaChief Medical Officer$639,239
Timothy MayerChief Operating Officer$633,181

The full NextCure compensation record

free company brief

This page is one person within NextCure's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are NextCure's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Richman's compensation dossier · One-time report. No refunds.